Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906316 · ClinicalTrials.gov registry record
A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
A clinical trial of Mycobacterium Avium Complex Pulmonary Disease, sponsored by Radboud University Medical Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 11
- Study locations
NCT05906316: Recruiting study of Mycobacterium Avium Complex Pulmonary Disease, sponsored by Radboud University Medical Center.
NCT05906316 is a study of Mycobacterium Avium Complex Pulmonary Disease that is actively recruiting participants, run by Radboud University Medical Center. The registered enrollment target is 100 participants. The trial reports 11 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05906316, a study of Mycobacterium Avium Complex Pulmonary Disease, is actively recruiting participants, sponsored by Radboud University Medical Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 11
- Study locations
Study Summary
To gain insight in the effectiveness of, adherence and adjustments to guideline-based three-drug antimycobacterial therapy in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) during the first 6 months of treatment.
Conditions Studied
Study Locations (11)
Other
- UZ Leuven - Leuven
- University Hospital Center Zagreb - Zagreb
- Aarhus University Hospital - Aarhus
- Rasmus Rude Laub - Hellerup
- University Hospital Frankfurt - Frankfurt
- Fukujuji Hospital - Tokyo
- Radboud University Medical Center - Nijmegen
- Seoul National University Hospital - Seoul
- Hospital Clínic de Barcelona - Barcelona
Oregon
- Oregon Science and Health University - Portland
Alberta
- University of Calgary - Calgary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2026-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05906316
The ClinicalTrials.gov registry entry for NCT05906316 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radboud University Medical Center, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mycobacterium Avium Complex Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05906316 reports 11 study locations spanning 3 distinct geographic areas - top geographies include Other, Oregon, Alberta.
Frequently Asked Questions
What is clinical trial NCT05906316 about?
NCT05906316 is a clinical study titled "A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study". To gain insight in the effectiveness of, adherence and adjustments to guideline-based three-drug antimycobacterial therapy in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) during the first 6 months of treatment.
What is the current status of trial NCT05906316?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-07-01. Estimated completion is 2026-07-01.
What conditions does trial NCT05906316 study?
This clinical trial studies the following conditions: Mycobacterium Avium Complex Pulmonary Disease.
Who is sponsoring clinical trial NCT05906316?
This trial is sponsored by Radboud University Medical Center, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05906316 being conducted?
This trial has 11 study locations across Oregon, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.